0001179110-21-002608.txt : 20210302 0001179110-21-002608.hdr.sgml : 20210302 20210302203231 ACCESSION NUMBER: 0001179110-21-002608 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210228 FILED AS OF DATE: 20210302 DATE AS OF CHANGE: 20210302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Michael Robert A. CENTRAL INDEX KEY: 0001699914 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35565 FILM NUMBER: 21706629 MAIL ADDRESS: STREET 1: 1 N. WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AbbVie Inc. CENTRAL INDEX KEY: 0001551152 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320375147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 BUSINESS PHONE: (847) 932-7900 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 4 1 edgar.xml FORM 4 - X0306 4 2021-02-28 0 0001551152 AbbVie Inc. ABBV 0001699914 Michael Robert A. 1 N. WAUKEGAN ROAD NORTH CHICAGO IL 60064 0 1 0 0 EVP, Chief Financial Officer Common Stock, $0.01 par value 2021-02-28 4 F 0 14006 107.74 D 37877 D Steven L. Scrogham, attorney-in-fact for Robert A. Michael 2021-03-02